Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18458
Country/Region: Botswana
Year: 2017
Main Partner: Government of Botswana
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $0
Testing: HIV Testing and Counseling (HVCT) $0
Treatment: Adult Treatment (HTXS) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 3,805
HTS_TST Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Female, Negative 2018 2,077
HTS_TST Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Male, Negative 2018 1,632
HTS_TST Sum of Test Result disaggregates 2018 96
HTS_TST_POS By Test Result: Positive 2018 96
HTS_TST_POS Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Female, Positive 2018 63
HTS_TST_POS Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Male, Positive 2018 33
TX_CURR Aggregated Age/Sex: 15+ Female 2018 9,514
TX_CURR Aggregated Age/Sex: 15+ Male 2018 4,868
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 14,382
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 14,382
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 14,382
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 84
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 37
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 121
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 121